1. Weaver BA. Epidemiology and natural history of genital human papillomavirus infection. J Am Osteopath
Assoc. 2006 Mar 1;106: 2-8.
2. American College of Obstetricians and Gynecologists ACOG practice Bulletin 45: Cervical Cytology
screening. International journal of gynaecology and obstetrics: the official organ of the International
Federation of Gynaecology and Obstetrics. 2003;102:417-27.
3. Koutsky L. Epidemiology of genital human papillomavirus infection. The American journal of medicine. 1997
May 5;102(5):3-8.
4. Mortazavi S, Zali M, Raoufi M, Nadji M, Kowsarian P, Nowroozi A. The prevalence of human papillomavirus
in cervical cancer in Iran. Asian Pac J Cancer Prev. 2002;3(1):69-72.
5. Zargar ZS, Darvishi M, Zangeneh M, Nazer M, Zargar ZS, Zargar A. Investigating knowledge and attitude of
medical students and other medical staff about HPV vaccination. NPWJM. 2018; 6 (19) :23-31.
6. Kolar SK, Wheldon C, Hernandez ND, Young L, Romero-Daza N, Daley EM. Human papillomavirus vaccine
knowledge and attitudes, preventative health behaviors, and medical mistrust among a racially and ethnically
diverse sample of college women. Journal of racial and ethnic health disparities. 2015 Mar 1;2(1):77-85.
7. Durusoy R, Yamazhan M, Tasbakan MI, Ergin I, Aysin M, Pullukçu H, Yamazhan T. HPV vaccine awareness
and willingness of first-year students entering university in Western Turkey. Asian Pac J Cancer Prev. 2010
Jan 1;11(6):1695-701.
8. Mostafavizadeh SM, Niakan M, Ahmadi A, Aghabozorgi S, Lak R, Azimi SA, et al. Frequency distribution of
HPV 18 based on the detection of E6 oncoprotein gene in cervix cancer samples. KAUMS Journal (FEYZ)
2013; 17(3): 287-93.
9. Dell DL, Chen H, Ahmad F, Stewart DE. Knowledge about human papillomavirus among adolescents.
Obstetrics & gynecology. 2000 Nov 1;96(5):653-6.
10. Pandhi D, Sonthalia S. Human papilloma virus vaccines: Current scenario. Indian Journal of sexually
transmitted diseases. 2011 Jul;32(2):75.
11. Berumen J, Ordoñez RM, Lazcano E, Salmeron J, Galvan SC, Estrada RA, Yunes E, Garcia-Carranca A,
Gonzalez-Lira G, Madrigal-De La Campa A. Asian-American variants of human papillomavirus 16 and risk
for cervical cancer: a case–control study. Journal of the National Cancer Institute. 2001 Sep 5;93(17):1325-30.
12. Parkin DM. Global cancer statistics in the year 2000. The lancet oncology. 2001 Sep 1;2(9):533-43.
13. Salehifar D, Lotfi R, Akbari Kamrani M. Knowledge about cervical cancer, human papilloma virus and
attitude towards acceptance of vaccination among female students. Payesh. 2015; 2: 217-26.
14. Medeiros R, Ramada D. Knowledge differences between male and female university students about human
papillomavirus (HPV) and cervical cancer: Implications for health strategies and vaccination. Vaccine. 2010
Dec 16;29(2):153-60.
15. Kwang NB, Yee CM, Shan LP, Teik CK, Chandralega KN, Kadir AK. Knowledge, perception and attitude
towards human papillomavirus among pre-university students in Malaysia. Asian Pac J Cancer Prev. 2014 Jan
1;15(21):9117-23.
16. Juni MH. Knowledge and perception of first year malay female undergraduate students at public university in
Malaysia towards Human Papillomavirus vaccination. International Journal of Public Health and Clinical
Sciences. 2014 Sep 6;1(1):49-58.
17. Pourkazemi A, Ghanbari A, Fakour F, Ghorbani S. Knowledge and Attitudes of Medical Students Toward
Human Papilloma Virus in Rasht, 2013. Journal of Guilan University of Medical Sciences. 2017 Feb
15;25(100):1-0.
18. Klug SJ, Hukelmann M, Blettner M. Knowledge about infection with human papillomavirus: a systematic
review. Preventive medicine. 2008 Feb 1;46(2):87-98.
19. Ghojazadeh M, Azar ZF, Saleh P, Naghavi-Behzad M, Azar NG. Knowledge and attitude of Iranian university
students toward human papilloma virus. Asian Pacific Journal of Cancer Prevention. 2012;13(12):6115-9.
20. Fakor F, Ghanbari khanghah A, Mahfouzi L, Dalil Heirati S F, Graili S. Knowledge and Attitudes of Medical
Students about Human Papilloma Virus (HPV) Vaccination and Associated Factors . J Holist Nurs Midwifery.
2016; 26 (4) :71-79.
21. Tripathy S, Mohapatra S, Muthulakshmi M, Rani R. Knowledge, attitude towards human papillomavirus and
HPV vaccine among medical students of a tertiary care teaching hospital in India. Int J Reprod Contracept
Obstet Gynecol. 2015;4(6):1771-4.
22. Liu A, Ho FK, Chan LK, Ng JY, Li SL, Chan GC, Leung TF, Ip P. Chinese medical students’ knowledge,
attitude and practice towards human papillomavirus vaccination and their intention to recommend the vaccine.
Journal of paediatrics and child health. 2018 Mar;54(3):302-10.
23. Shetty S, Prabhu S, Shetty V, Shetty AK. Knowledge, attitudes and factors associated with acceptability of
human papillomavirus vaccination among undergraduate medical, dental and nursing students in South India.
Human vaccines & immunotherapeutics. 2019 Feb 18:1-0.
24. Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's Principles of Internal
Medicine, (Vol. 1 & Vol. 2). McGraw Hill Professional; 2018 Feb 6.
25. Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARCInformation
Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and RelatedDiseases in the
World. Summary Report 17 June 2019.
26. https://dna-lab.ir
27. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer
incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International
journal of cancer. 2015: 1;136(5):E359-86.
28. Hajibagheri K, Abaszade A, Afrasiabian S, Verdi F, Roshani D, Abdi F, Mohsenpour B. Frequency of human
papilloma virus genotypes among woman with genital lesions, in Sanandaj, Iran. Scientific Journal of
Kurdistan University of Medical Sciences, 2018, 23(4):46-52.
29. Eghbali S, Amirinejad R, Obeidi N, Mosadeghzadeh S, Vahdat K, Azizi F, et al . Oncogenic human
papillomavirus genital infection in southern Iranian women: populationbased study versus clinic-based data.
Virol J 2012; 9: 194.
30. Safaei A, Khanlari M, Momtahen M, Monabati A, Robati M, Amooei S, et al . Prevalence of high-risk human
papillomavirus types 16 and 18 in healthy women with cytologically negative pap smear in Iran. Indian J
Pathol Microbiol 2010; 53: 681-5.
31. Khodakarami N, Clifford GM, Yavari P, Farzaneh F, Salehpour S, Broutet N, et al . Human papillomavirus
infection in women with and without cervical cancer in Tehran, Iran. Int J Cancer 2012; 131: E156-61.
32. Hamkar R, Azad TM, Mahmoodi M, Seyedirashti S, Severini A, Nategh R. Prevalence of human
papillomavirus in Mazandaran Province, Islamic Republic of Iran. East Mediterr Health J 2002;8:805-11.
33. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection
among females in the United States. JAMA 2007; 297: 813–9.
34. Manhart LE, Holmes KK, Koutsky LA, Wood TR, Kenney DL, Feng Q, et al. Human papillomavirus infection
among sexually active young women in the United States: implications for developing a vaccination strategy.
Sex Transm Dis 2006; 33: 502–8.
35. Shabani M, Sadeh M, Falsafi S. The Prevalence of Papillomavirus-16 and-18 isolated from women with
cervical cancer using Multiplex PCR. Yafteh. 2019;20(4).
36. Jabbarpour Bonyadi M, Esmaeili M, Dastranj A. Oncogene HPV types determined by PCR in multiple lesions
of cervical cancer in the North West of Iran. J Infec Dis Trop Med. 2008;13(41):29-34.
37. Jahdi F, Khademi K, Khoei EM, Haghani H, Yazdanpanahi Z. Evaluation of the individual and medical factors
associated with genital human papillomavirus in Iranian women. Scimetr. 2014 Oct;2(4).
38. Khorasanizadeh F, Hassanloo J, Khaksar N, Taheri SM, Marzaban M, Rashidi BH, et al. Epidemiology of
cervical cancer and human papilloma virus infection among Iranian women—Analyses of national data and
systematic review of the literature. Gynecol Oncol. 2013;128(2):277-81.
39. Yousefzadeh A, Mostafavizadeh SM, Jarollahi A, Raeisi M, Garshasbi M, Siavashvahabi Z, et al. Human
papillomavirus (HPV) prevalence and types among women attending regular gynecological visit in Tehran,
Iran. Clin Lab. 2014;60(2):267-73.
40. Giorgi Rossi P, Baldacchini F, Ronco G. The possible effects on socio-economic inequalities of introducing
HPV testing as primary test in cervical cancer screening programs. Front Oncol. 2014;4:20.
41. Jamali B, Jamali S. Relative Frequency of Human papillomavirus Genotypes and its Related Characteristics in
Women Referred to Alzahra Hospital in Tabriz. Iran J Med Microbiol. 2018; 12 (1) :51-60.
42. Dadashi M., Vaezjalali M., Fallah F., Goudarzi H., Nasiri M-J, Owlia P, Hashemi A, Darban-Sarokhalil D.
Epidemiology of Human Papillomavirus (HPV) Infection among Iranian Women with Cervical Infections: A
Systematic Review and Meta-Analysis of National Data, Infection, Epidemiology and Medicine. 2017; 3(2):
68-72.
43. León-Maldonado L, Wentzell E, Brown B, Allen-Leigh B, Torres-Ibarra L, Salmerón J, et al. Perceptions and
experiences of human papillomavirus (HPV) infection and testing among low-income Mexican women. PloS
One. 2016; 11(5):e0153367.
44. Joura EA, Giuliano AR, Iversen O-E, Bouchard C, Mao C, Mehlsen J, et al. A 9-valent HPV vaccine against
infection and intraepithelial neoplasia in women. N Engl J Med. 2015; 372(8):711-23.
45. Printz C. FDA approves Gardasil 9 for more types of HPV. Cancer. 2015;121(8):1156-7.
46. Tjalma WA. There are two prophylactic human papillomavirus vaccines against cancer, and they are different.
J Clin Oncol. 2015: 33(8):964-65.
47. Delany-Moretlwe S, Cowan FM, Busza J, Bolton-Moore C, Kelley K, Fairlie L. Providing comprehensive
health services for young key populations: needs, barriers and gaps. HIV and adolescents: focus on young key
populations. J Int AIDS Soc. 2015:8(2 suppl1);19833.
48. Owsianka B, Gańczak M. Evaluation of human papilloma virus (HPV) vaccination strategies and vaccination
coverage in adolescent girls worldwide. Przegl Epidemiol. 2015; 69(1):53-8.
49. Karimi R. Easy statistical analysis guide with SPSS. Hengam publishing, Summer, 2015.
50. Kang HS, Moneyham L. Attitudes toward and intention to receive the human papilloma virus (HPV)
vaccination and intention to use condoms among female Korean college students. Vaccine. 2010 Jan
8;28(3):811-6.
51. Wong LP, Sam IC. Ethnically diverse female university students’ knowledge and attitudes toward human
papillomavirus (HPV), HPV vaccination and cervical cancer. European Journal of Obstetrics & Gynecology
and Reproductive Biology. 2010 Jan 1;148(1):90-5.
52. Rashwan HH, Saat NZ, Manan DN. Knowledge, attitude and practice of malaysian medical and pharmacy
students towards human papillomavirus vaccination. Asian Pacific Journal of Cancer Prevention.
2012;13(5):2279-83.
53. Yacobi E, Tennant C, Ferrante J, Pal N, Roetzheim R. University students' knowledge and awareness of HPV.
Preventive medicine. 1999 Jun 1;28(6):535-41.
54. Gerend MA, Magloire ZF. Awareness, knowledge, and beliefs about human papillomavirus in a racially
diverse sample of young adults. Journal of Adolescent Health. 2008 Mar 1;42(3):237-42.
55. Holcomb B, Bailey JM, Crawford K, Ruffin MT. Adults’ knowledge and behaviors related to human
papillomavirus infection. The Journal of the American Board of Family Practice. 2004 Jan 1;17(1):26-31.
56. Walsh CD, Gera A, Shah M, Sharma A, Powell JE, Wilson S. Public knowledge and attitudes towards Human
Papilloma Virus (HPV) vaccination. BMC public Health. 2008 Dec 23;8(1):368.
)